Zomedica Corp.
ZOM was delisted on the 4th of March, 2025.
35 hedge funds and large institutions have $28.6M invested in Zomedica Corp. in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 6 reducing their positions, and 6 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 6
5% less funds holding
Funds holding: 37 → 35 (-2)
16% less capital invested
Capital invested by funds: $33.8M → $28.6M (-$5.28M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
+$618K |
| 2 |
BlackRock
New York
|
+$316K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$71.5K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$40.1K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$37.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$672K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$30K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$23K |
| 4 |
Morgan Stanley
New York
|
-$10.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9K |
ZOM Hedge Fund Activity: Q3 2018 in Review
35 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Zomedica Corp. (ZOM) for Q3 2018, worth a combined $28.6M — down 16% from $33.8M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ZOM and 4 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 14 added.
The largest buyer was Northern Trust, adding an estimated $618K. The largest seller was State Street, exiting entirely with an estimated $672K sold.
- 35 institutional investors held Zomedica Corp. (ZOM) as of Q3 2018, down from 37 in Q2 2018.
- Funds reported $28.6M of Zomedica Corp. stock for Q3 2018, down 16% quarter-over-quarter.
- 4 funds opened new Zomedica Corp. positions in Q3 2018 and 6 closed out, a net change of -2 holders.
- The largest Zomedica Corp. buyer in Q3 2018 was Northern Trust, an estimated $618K added.
- The largest Zomedica Corp. seller in Q3 2018 was State Street, an estimated $672K sold.
Based on aggregated 13F filings for Q3 2018.